Literature DB >> 26825950

Our paper 20 years later: the unfulfilled promises of nebulised adrenaline in acute severe asthma.

Fekri Abroug1,2, Fahmi Dachraoui3,4, Lamia Ouanes-Besbes3,4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26825950     DOI： 10.1007/s00134-016-4210-1

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  18 in total

Review 1.  Beta-agonist intrinsic efficacy: measurement and clinical significance.

Authors:  Nicola A Hanania; Amir Sharafkhaneh; Roger Barber; Burton F Dickey
Journal:  Am J Respir Crit Care Med       Date:  2002-05-15       Impact factor: 21.405

2.  Continuous versus intermittent nebulization of salbutamol in acute severe asthma: a randomized, controlled trial.

Authors:  L Besbes-Ouanes; S Nouira; S Elatrous; J Knani; M Boussarsar; F Abroug
Journal:  Ann Emerg Med       Date:  2000-09       Impact factor: 5.721

3.  The efficacy of nebulized racemic epinephrine in children with acute asthma: a randomized, double-blind trial.

Authors:  A C Plint; M H Osmond; T P Klassen
Journal:  Acad Emerg Med       Date:  2000-10       Impact factor: 3.451

4.  Inhaled salbutamol (albuterol) vs injected epinephrine in the treatment of acute asthma in children.

Authors:  A B Becker; N A Nelson; F E Simons
Journal:  J Pediatr       Date:  1983-03       Impact factor: 4.406

5.  [Dose-effect of adrenaline nebulization in asthma: comparative study with salbutamol].

Authors:  S Elatrous; H Elidrissi; H Trabelsi; R Boujdaria; M Boussarsar; L Ouannes; K Bouzouita; S Nouira; M F Abroug
Journal:  Rev Pneumol Clin       Date:  1997

6.  [Comparative efficiency of nebulized adrenaline and salbutamol in severe acute asthma. A randomized, controlled prospective study].

Authors:  A A Zeggwagh; R Abouqal; N Madani; K Abidi; R Moussaoui; A Zekraoui; O Kerkeb
Journal:  Ann Fr Anesth Reanim       Date:  2002-11

7.  Comparison of the effects of salbutamol and adrenaline on airway smooth muscle contractility in vitro and on bronchial reactivity in vivo.

Authors:  D R Baldwin; Z Sivardeen; I D Pavord; A J Knox
Journal:  Thorax       Date:  1994-11       Impact factor: 9.139

8.  Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Authors: 
Journal:  Lancet       Date:  2014-12-18       Impact factor: 79.321

Review 9.  EAACI position statement on asthma exacerbations and severe asthma.

Authors:  A Custovic; S L Johnston; I Pavord; M Gaga; L Fabbri; E H Bel; P Le Souëf; J Lötvall; P Demoly; C A Akdis; D Ryan; M J Mäkelä; F Martinez; J W Holloway; S Saglani; P O'Byrne; A Papi; S Sergejeva; A Magnan; S Del Giacco; O Kalayci; E Hamelmann; N G Papadopoulos
Journal:  Allergy       Date:  2013-11-06       Impact factor: 13.146

10.  "Causes of death in asthma, COPD and non-respiratory hospitalized patients: a multicentric study".

Authors:  Jose Gregorio Soto-Campos; Vicente Plaza; Joan B Soriano; Carlos Cabrera-López; Carlos Almonacid-Sánchez; Rosa Vazquez-Oliva; Jose Serrano; Aitor Ballaz-Quincoces; Alicia Padilla-Galo; Vanessa Santos
Journal:  BMC Pulm Med       Date:  2013-12-10       Impact factor: 3.317
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.